We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

World's First Breathalyzer to Detect Infectious Diseases

By HospiMedica International staff writers
Posted on 16 Mar 2023
Print article
Image: An affordable and easy to use breathalyzer can accurately detect infectious diseases to help millions of people (Photo courtesy of Noze)
Image: An affordable and easy to use breathalyzer can accurately detect infectious diseases to help millions of people (Photo courtesy of Noze)

Healthcare screenings and diagnostics can be a hassle - they take up time, are invasive, expensive, and may not be equally accessible to all social groups. However, the air that we exhale is a rich source of information about our current health. The exchange that occurs between the blood and the air in the lungs allows for an accurate representation of diseases through their unique metabolic biomarkers. Now, an AI-powered breathalyzer designed to examine these metabolic biomarkers could enable quick, inexpensive, diagnosis of various diseases.

Noze (Montreal, Canada), an AI startup that has developed a technology to digitize the sense of smell, is building a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs). This will allow for the rapid screening and diagnostics of infectious diseases like malaria and tuberculosis which are highly prevalent, especially in developing countries. Malaria, which is recognized as one of the most significant global public health crises, is both a leading cause of disease and death in developing countries, causing more harm to young children and expectant mothers. Noze’s long-term goal is to ensure global access to an efficient detection device, which can help mitigate the transmission of such diseases, enable early treatment, and enhance patient outcomes in developing countries.

Noze continues to advance and improve its AI-based digital odor perception platform, with a particular emphasis on medical and health issues. During the COVID-19 pandemic, Noze's technology took center stage when it was the first to detect the airborne markers released by individuals infected with coronavirus and influenza. This groundbreaking achievement has unlocked new possibilities in healthcare by using digital sense of smell to tackle diagnostic challenges. Noze is committed to developing a diagnostic breathalyzer by the end of 2023 with plans for clinical validation soon after.

"Breath-based diagnostics will be a game-changer for healthcare accessibility, and our ability to launch a portable device and deliver it on a massive, worldwide scale can be a powerful new tool to fight the spread of Malaria and Tuberculosis, in addition to many other diseases," said Karim Aly, CEO at Noze.

Related Links:

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
Transvaginal Tube
LiNA McCartney Tube

Print article


Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.